UCB's Global Corporate Website

Shareholders meeting 2016

28 April 2016

Documents ENG FR NL
Convening notice (including agenda/
attendance formalities)
PDF PDF PDF

Proxy

PDF

PDF

PDF

UCB Group - 
2015 annual report

PDF

PDF

PDF

UCB SA/NV -
2015 statutory annual accounts

PDF PDF PDF

UCB SA/NV - 
Management report

PDF PDF PDF

UCB SA/NV -
Report of the Statutory Auditor

PDF

PDF

PDF

Special report of the Board
Art. 604 Belgian Companies Code

PDF

PDF

PDF

Proposed resolutions and comments
from the Board of Directors:
see convening notice

 

 

 

To be elected:

Pierre Gurdjian

Pierre Gurdjian is a senior professional in the field of Philanthropy and Education. He is Philanthropy Partner of the RVVZ Foundation since the beginning of 2015, and President of the Board of Directors of the Université Libre de Bruxelles, effective January 2016 .

Before he was a Senior Partner at McKinsey and Co. where he was active for nearly three decades. He led the Belgian office between 2005 and 2012. His professional focus centered on supporting organizations through major change and developing human capital, particularly the leadership of their top teams. He pursued a strong interest in drawing lessons of leadership from philosophy and wisdom.

He teaches a graduate course in CEO Leadership at the Solvay Business School of the Université Libre de Bruxelles.

close

Cyril Janssen

Ulf Wiinberg is a pharmaceutical industry professional. Ulf started as a sales representative at Lederle Laboratories in Sweden, which later was acquired by Wyeth. At Wyeth, Ulf was President of the global consumer health care business, and later President for the European pharma business and strategically responsible for biotechnology and vaccines. Ulf served as a member of the management committee from 2002-2008. From 2008 to end of 2014, Ulf was the CEO of Lundbeck, a Danish company focusing on brain diseases.

During his career, Ulf has worked on development and in production of pharmaceutical products and vaccines that can make a big difference for patients. Ulf has also served on the boards of the industry associations for the pharmaceutical and consumer healthcare business, Pharma, Efpia and WSMI.

Ulf is today a non-executive Board member at Alfa Laval, a Swedish industrial company, and Nestle Health and Science, a consumer healthcare company. He is also the Chairman of Avillion, a company that helps large pharmaceutical companies finance and operate late stage development programs.

close
Documents post-AGM ENG FR NL

Minutes of the 
Ordinary General Meeting

PDF PDF PDF

Minutes of the 
Extraordinary General Meeting

PDF

PDF

PDF

Next AGM meeting

Annual shareholders' meeting

Details to be communicated closer to the date.

 

Shareholders' meeting archives

 

Questions?

Please send your questions to shareholders.meeting@ucb.com